Peter Davies
Net worth: 669 $ as of 31/05/2026
Net worth: 669 $ as of 31/05/2026
Peter Miles Winston Davies is currently an Independent Non-Executive Director at Bionomics Ltd. since 2021, an Independent Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, and Chief Business Officer at Leaf4life, Inc. Formerly, Mr. Davies was Managing Director at Apeiron Investment Group Ltd. from 2021 to 2022.
Education includes graduation from The University of Edinburgh.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0% | 20/01/2026 | 126 ( 0% ) | 669 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Director/Board Member | 01/07/2021 |
Leaf4life, Inc. | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Private Equity Investor | 01/01/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Finance |
Leaf4life, Inc. | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions